BAM-1110

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBAM-1110
Drug Alias NameBAM-1110
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D1 receptor agonistsDopamine D2 receptor agonists
TargetsDopamine D1 receptorDopamine D2 receptor
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNichi-Iko Pharmaceutical Co LtdAlfresa Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlfresa PharmaNichi-Iko Pharmaceutical Co LtdMitsubishi Tanabe Pharma
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A